| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |